Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT06290934 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: emvistegrast
DRUG: Placebo-to-match emvistegrast

Sponsor

Gilead Sciences